1. Home
  2. BNTX vs TEVA Comparison

BNTX vs TEVA Comparison

Compare BNTX & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$95.41

Market Cap

24.8B

Sector

Health Care

ML Signal

HOLD

Logo Teva Pharmaceutical Industries Limited

TEVA

Teva Pharmaceutical Industries Limited

HOLD

Current Price

$31.42

Market Cap

30.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNTX
TEVA
Founded
2008
1901
Country
Germany
Israel
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.8B
30.2B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
BNTX
TEVA
Price
$95.41
$31.42
Analyst Decision
Buy
Strong Buy
Analyst Count
11
9
Target Price
$137.40
$32.11
AVG Volume (30 Days)
1.5M
9.3M
Earning Date
11-03-2025
01-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.62
Revenue
$3,698,814,972.00
$16,776,000,000.00
Revenue This Year
$2.03
$4.62
Revenue Next Year
N/A
$0.34
P/E Ratio
N/A
$51.14
Revenue Growth
3.70
0.02
52 Week Low
$81.20
$12.47
52 Week High
$129.27
$31.99

Technical Indicators

Market Signals
Indicator
BNTX
TEVA
Relative Strength Index (RSI) 47.15 77.93
Support Level $94.00 $31.17
Resistance Level $96.19 $31.99
Average True Range (ATR) 1.80 0.58
MACD 0.50 -0.07
Stochastic Oscillator 68.59 81.76

Price Performance

Historical Comparison
BNTX
TEVA

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Share on Social Networks: